Leiomyosarcoma clinical trials at UCSF
2 in progress, 1 open to eligible people
Leiomyosarcoma is a cancer that affects the body's smooth muscles. At UCSF, researchers are running trials to learn how new treatments work in patients who have had other treatments. One trial is examining ADI-PEG 20 in combination with chemotherapy drugs.
ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
open to eligible people ages 18-99
To compare the efficacy and safety in subjects with advanced or metastatic LMS previously treated with an anthracycline.
San Francisco, California and other locations
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
Sorry, in progress, not accepting new patients
This randomized phase II/III trial studies how well pazopanib, when combined with chemotherapy and radiation therapy or radiation therapy alone, work in the treatment of patients with newly diagnosed non-rhabdomyosarcoma soft tissue sarcomas that…
Oakland, California and other locations
Our lead scientists for Leiomyosarcoma research studies include Varun Monga, M.D.
Last updated: